Literature DB >> 7882278

Non-Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases.

S L Abbondanzo1, B M Wenig.   

Abstract

BACKGROUND: Non-Hodgkin's lymphomas (NHLs) of the sinonasal tract are uncommon neoplasms that can be morphologically difficult to distinguish from destructive nonneoplastic processes or other malignant neoplasms in this site.
METHODS: From the files of the Otolaryngic Tumor Registry-Armed Forces Institute of Pathology from 1965 to 1992, 120 cases of NHL involving the sinonasal tract were selected for which clinical records and paraffin-embedded tissue blocks were available. The histologic features and immunophenotypic findings of each patient were examined, and follow-up data were obtained for 66 (55%).
RESULTS: The ratio of males to females was 1.35:1, and the ages ranged from 3 to 94 years (median, 59 years). Sixty percent of the cases of NHL occurred in the patients' sixth to eighth decades of life. Clinical presentations varied according to histologic type. The low grade lymphomas presented with a nasal cavity or paranasal sinus mass associated with obstructive symptoms. The high grade lymphomas were more likely to present with aggressive signs and symptoms including nonhealing ulcer, cranial nerve manifestations, facial swelling, epistaxis, or pain. Of note, the high grade B-cell lymphomas tended to present with soft tissue or osseous destruction, particularly of the orbit with associated proptosis, whereas the T-cell lymphomas were associated with nasal septal perforation and/or destruction. Sites of disease included the nasal cavity, one or more paranasal sinuses, or multiple regions within the sinonasal tract. Of patients who received adequate follow-up, nodal and extranodal dissemination were identified in a limited number (n = 11). Nodal dissemination occurred in cervical and axillary lymph nodes. Extranodal sites of involvement included the larynx, skin, liver, uvula, kidney, breast, lacrimal gland, testis, and prostate gland. There was a wide spectrum of morphologic types of lymphoma, classified according to the Working Formulation. Immunophenotypic analysis on paraffin embedded tissue sections of all patients demonstrated a B-cell to T-cell ratio of 1.18:1. Treatment primarily included radiotherapy and chemotherapy. Follow-up information was available for 66 (55%) patients ranging from 1 to 16 years (median, 3 years). Of these 66 patients, 24 (36.4%) died of disease, 17 (25.7%) are alive without disease, 13 (19.7%) are alive with disease, and 12 (18.2%) are dead of unrelated or unknown causes.
CONCLUSIONS: Non-Hodgkin's lymphomas of the sinonasal tract are heterogeneous diseases that can be clinically aggressive. The frequency of these lymphomas in the United States cannot be estimated accurately because all of our cases were of histologic slides submitted for consultations. There appears, however, to be a slight B-cell predominance in this population that previously has been observed, unlike in South America and Asia where the majority of cases have a T-cell phenotype.

Entities:  

Mesh:

Year:  1995        PMID: 7882278     DOI: 10.1002/1097-0142(19950315)75:6<1281::aid-cncr2820750610>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  Nasal NK/T-cell-lymphoma metastazising into the masseteric muscle mimicking a parotid mass.

Authors:  M Jaehne; K T Jäkel; J Ussmüller; A C Feller
Journal:  Virchows Arch       Date:  2001-10       Impact factor: 4.064

Review 2.  Hematolymphoid lesions of the sinonasal tract.

Authors:  Genevieve M Crane; Amy S Duffield
Journal:  Semin Diagn Pathol       Date:  2015-09-09       Impact factor: 3.464

3.  Isolated skeletal muscle recurrence of the paranasal sinus lymphoma in complete remission.

Authors:  Hakan Karagol; Duygu Derin; Mert Basaran; Sevil Bavbek
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

4.  T/NK cell lymphoma presenting as a "blocked nose".

Authors:  Naomi Ketharanathan; Peter Jan van Kipshagen; Wies Vasmel; Ellis Barbé; Nico de Vries
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-01-11       Impact factor: 2.503

5.  Clinical findings of extranodal SNT lymphoid malignancies in a four-decade single-centre series.

Authors:  Pauli Vähämurto; Kaija Silventoinen; Seija I Vento; Marja-Liisa Karjalainen-Lindsberg; Aaro Haapaniemi; Leif Bäck; Susanna Mannisto; Sirpa Leppä; Antti A Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-24       Impact factor: 2.503

6.  The diagnosis of sinonasal lymphoma: a challenge for rhinologists.

Authors:  Ting-Ting Yen; Ren-Ching Wang; Rong-San Jiang; Shyh-Chang Chen; Shang-Heng Wu; Kai-Li Liang
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-26       Impact factor: 2.503

7.  Nasal septal perforation in a patient with subclinical celiac disease: a possible new association.

Authors:  A Medina-Banegas; F A Pastor-Quirante; J Osete-Albaladejo; E López-Meseguer; F López-Andreu
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-10-22       Impact factor: 2.503

Review 8.  Receptor-directed therapy of T-cell leukemias and lymphomas.

Authors:  John C Morris; Thomas A Waldmann; John E Janik
Journal:  J Immunotoxicol       Date:  2008-04       Impact factor: 3.000

9.  Rhesus lymphocryptovirus type 1-associated B-cell nasal lymphoma in SIV-infected rhesus macaques.

Authors:  A K Marr-Belvin; A K Carville; M A Fahey; K Boisvert; S A Klumpp; M Ohashi; F Wang; S P O'Neil; S V Westmoreland
Journal:  Vet Pathol       Date:  2008-11       Impact factor: 2.221

10.  Extranodal T-cell lymphoma of nasal cavity.

Authors:  Madhu Kumar; Ashutosh Kumar; Madhu Mati Goel
Journal:  Indian J Hematol Blood Transfus       Date:  2012-01-31       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.